Berlin, Germany

Aptarion Biotech Ag


USPTO Granted Patents = 5



Forward Citations = 1

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Sven Klussmann (4 out of 32 patents)

silverMedal Axel Vater (3 out of 12 patents)

bronzeMedal Kai Hohlig (3 out of 7 patents)

4.  Christian Maasch (3 out of 26 patents)

5.  Andreas Pech (2 out of 3 patents)

6.  Ralf David (2 out of 3 patents)

7.  Florian Jarosch (2 out of 22 patents)

8.  Michael Jahnz (2 out of 3 patents)

9.  Klaus Buchner (2 out of 21 patents)

10.  Dirk Zboralski (1 out of 6 patents)

11.  Werner Purschke (1 out of 20 patents)

12.  Simone Sell (2 patents)

13.  Kai HÖHLIG (0 patent)


5 patents:

Company Overview
Aptarion Biotech AG is a biotechnology company focused on developing innovative solutions for the healthcare sector. The company specializes in the research and development of advanced therapeutic products and technologies aimed at improving patient outcomes. With a commitment to scientific excellence and collaboration, Aptarion Biotech leverages cutting-edge research to address unmet medical needs. Their portfolio includes a range of biopharmaceuticals and diagnostic tools designed to enhance treatment efficacy and safety. The company is dedicated to advancing the field of biotechnology through rigorous clinical trials and partnerships with leading research institutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#179 in D-1000 Berlin

#6,097 in Germany

Berlin, DE
Berlin, Germany
Forward Citations = 1

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aptarion Biotech Ag. Retrieved from https://idiyas.com/company/aptarion-biotech-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…